Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
-0.0002
%
−2,38%
Latest
0.0082
High
0.0086
Low
0.0078
Volume
7 122 592
Turnover (SEK)
55 917
Market Value (MSEK)
10,8
Time (Latest trade)

Board

CEO

  • Tore Duvold

Chairperson of the Board

  • Ulrik Spork

Board

  • Christina Östberg Lloyd
  • Ingela Liljeqvist Soltic
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Videos

Largest Owners

Name Capital % Votes % Date
Flexmedical Solutions Limited 8,78 8,78 2024-12-23
JEQ Capital AB 5,93 5,93 2024-12-23
Per Robert Anderson 5,93 5,93 2024-12-23
Stefan Lundgren 3,98 3,98 2024-12-23
Peter Nilsson 3,56 3,56 2024-12-23
Avanza Pension 3,21 3,21 2024-12-23
John Moll 2,97 2,97 2024-12-23
Alexander Schoeneck 2,97 2,97 2024-12-23
Love Carlsson 2,97 2,97 2024-12-23
Tommy Ure 2,65 2,65 2024-12-23
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2025-02-12 Bokslutskommuniké 2024

  • 2025-02-17 Extra bolagsstämma 2025

  • 2025-05-07 Delårsrapport 2025-Q1

  • 2025-08-20 Delårsrapport 2025-Q2

  • 2025-11-12 Delårsrapport 2025-Q3